- Open
- 71.80
- High
- 71.80
- Low
- 68.50
- Close
- 68.50
- Change
- -3.00 (-4.21%)
- Volume
- 445,782
| 16 Oct 2026 | 07:00:07 | Microbiotica raises £36m in Series C financing |
| 12 Oct 2026 | 07:00:10 | IP Group leads round in Matter Machine |
| 9 Oct 2026 | 09:24:42 | Holding(s) in Company |
| 2 Oct 2026 | 07:00:03 | IP Group completes partial realisation in ONT |
| 16 Apr 2026 | Annual Report and Accounts | |
| 25 Jun 2025 | Annual Report and Accounts | |
| 10 Jun 2025 | Annual Report and Accounts |
IP Group plc specializes in the commercialization of intellectual property by creating and developing businesses based on proprietary technologies. The company focuses on identifying, funding, and supporting early-stage companies across various sectors, including life sciences, technology, and engineering. It operates primarily in the United Kingdom and has a portfolio of investments in companies at different stages of development, from early-stage startups to more established entities.
| 16 Oct 2026 | 07:00:07 | Microbiotica raises £36m in Series C financing |
| 12 Oct 2026 | 07:00:10 | IP Group leads round in Matter Machine |
| 9 Oct 2026 | 09:24:42 | Holding(s) in Company |
| 2 Oct 2026 | 07:00:03 | IP Group completes partial realisation in ONT |
| 16 Apr 2026 | Annual Report and Accounts | |
| 25 Jun 2025 | Annual Report and Accounts | |
| 10 Jun 2025 | Annual Report and Accounts |
IP Group plc specializes in the commercialization of intellectual property by creating and developing businesses based on proprietary technologies. The company focuses on identifying, funding, and supporting early-stage companies across various sectors, including life sciences, technology, and engineering. It operates primarily in the United Kingdom and has a portfolio of investments in companies at different stages of development, from early-stage startups to more established entities.
| 15 Sept 2026 | 07:00:04 | Half-year Financial Report |
| 16 Oct 2026 |
| IP Group invests in Microbiotica funding round, Man Group AuM rises to $271bn in Q3 |
| 16 Oct 2026 | IP Group’s Microbiotica raises £36m to advance gut drug to Phase 2 |
| 12 Oct 2026 | IP Group leads £4m funding round for AI materials spin‑out Matter Machine |
| 11 Oct 2026 | AI university spin-out led by former Oxford Nanopore boss raises £4m |
| 2 Oct 2026 | IP Group crystallises £21m of Oxford Nanopore shares, keeps majority of stake |
| 2 Oct 2026 | IP Group sells down stake in Oxford Nanopore |
| 15 Sept 2026 | 07:00:04 | Half-year Financial Report |
| 16 Oct 2026 |
| IP Group invests in Microbiotica funding round, Man Group AuM rises to $271bn in Q3 |
| 16 Oct 2026 | IP Group’s Microbiotica raises £36m to advance gut drug to Phase 2 |
| 12 Oct 2026 | IP Group leads £4m funding round for AI materials spin‑out Matter Machine |
| 11 Oct 2026 | AI university spin-out led by former Oxford Nanopore boss raises £4m |
| 2 Oct 2026 | IP Group crystallises £21m of Oxford Nanopore shares, keeps majority of stake |
| 2 Oct 2026 | IP Group sells down stake in Oxford Nanopore |
| Issuer | Mkt cap | 1Y |
|---|---|---|
IPOIP Group plc | £605m | +0.3% |
| £134m | +0.0% | |
| £4m | -0.1% | |
| £2m | +0.3% | |
| £2m | -0.6% | |
| £2m | -0.6% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
IPOIP Group plc | £605m | +0.3% |
| £134m | +0.0% | |
| £4m | -0.1% | |
| £2m | +0.3% | |
| £2m | -0.6% | |
| £2m | -0.6% |
